Literature DB >> 23632760

The impact of the body mass index on outcome after subarachnoid hemorrhage: is there an obesity paradox in SAH? A retrospective analysis.

Johannes Platz1, Erdem Güresir, Patrick Schuss, Jürgen Konczalla, Volker Seifert, Hartmut Vatter.   

Abstract

BACKGROUND: Obesity is a risk factor for cardiovascular disease and associated with a poor outcome, especially for intensive care patients. However, recent studies have described favorable outcomes of obese patients after stroke, a phenomenon called the "obesity paradox."
OBJECTIVE: To assess the impact of the body mass index (BMI) on outcome after subarachnoid hemorrhage (SAH).
METHODS: We analyzed the data for 741 SAH patients. A BMI greater than 25 kg/m(2) was considered overweight and greater than 30 kg/m(2) obese. The outcome according to the Glasgow Outcome Scale at discharge and after 6 months was assessed using logistic regression analysis.
RESULTS: According to the BMI, 268 patients (36.2%) were overweight and 113 (15.2%) were obese. A favorable outcome (Glasgow Outcome Scale score >3) was achieved in 53.0% of overweight patients. In contrast, 61.4% of the 360 patients with a normal BMI had a favorable outcome (P = .021). However, in the multivariate analysis, only age (odds ratio [OR]: 1.051, 95% confidence interval [CI]: 1.04-1.07, P < .001), World Federation of Neurological Surgeons grade (OR: 2.095, 95% CI: 1.87-2.35, P < .001), occurrence of vasospasm (OR: 2.90, 95% CI: 1.94-4.34, P < .001), and aneurysm size larger than 12 mm (OR: 2.215, 95% CI: 1.20-4.10, P = .011) were independent predictors of outcome after 6 months. Of the 321 poor grade patients (World Federation of Neurological Surgeons score >3), 171 (53.3%) were overweight. Of these, 21.6% attained a favorable outcome compared with 35.3% of normal-weight patients (P = .006).
CONCLUSION: Although many physicians anticipate a worse outcome for obese patients, in our study, the BMI was not an independent predictor of outcome. Based on the BMI, obesity seems to be negligible for outcome after SAH compared with the impact of SAH itself, the patient's age, occurrence of vasospasm, or aneurysm size.

Entities:  

Mesh:

Year:  2013        PMID: 23632760     DOI: 10.1227/01.neu.0000430322.17000.82

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Methazolamide improves neurological behavior by inhibition of neuron apoptosis in subarachnoid hemorrhage mice.

Authors:  Mingchang Li; Wei Wang; Haojian Mai; Xinmu Zhang; Jian Wang; Yufeng Gao; Yuefei Wang; Gang Deng; Ling Gao; Shuanhu Zhou; Qianxue Chen; Xin Wang
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

Review 2.  Obesity and Stroke: Does the Paradox Apply for Stroke?

Authors:  Gabriel A Quiñones-Ossa; Carolina Lobo; Ezequiel Garcia-Ballestas; William A Florez; Luis Rafael Moscote-Salazar; Amit Agrawal
Journal:  Neurointervention       Date:  2021-01-04

3.  Body Mass Index and the Risk of Poor Outcome in Surgically Treated Patients With Good-Grade Aneurysmal Subarachnoid Hemorrhage.

Authors:  Ilari Rautalin; Seppo Juvela; R Loch Macdonald; Miikka Korja
Journal:  Neurosurgery       Date:  2022-03-24       Impact factor: 5.315

4.  Obesity paradox in subarachnoid hemorrhage: a systematic review.

Authors:  Ilari Rautalin; Jaakko Kaprio; Miikka Korja
Journal:  Neurosurg Rev       Date:  2019-10-29       Impact factor: 3.042

5.  Body mass index and leptin levels in serum and cerebrospinal fluid in relation to delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Michael Veldeman; Miriam Weiss; Tim Philipp Simon; Anke Hoellig; Hans Clusmann; Walid Albanna
Journal:  Neurosurg Rev       Date:  2021-04-17       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.